1. Home
  2. CTSO vs GSIW Comparison

CTSO vs GSIW Comparison

Compare CTSO & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.45

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

GSIW

Garden Stage Limited

HOLD

Current Price

$31.67

Market Cap

33.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
GSIW
Founded
1997
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
33.5M
IPO Year
2008
2022

Fundamental Metrics

Financial Performance
Metric
CTSO
GSIW
Price
$0.45
$31.67
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
77.1K
1.7K
Earning Date
05-01-2026
08-04-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
N/A
Revenue Next Year
$22.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.44
$0.05
52 Week High
$1.39
$36.90

Technical Indicators

Market Signals
Indicator
CTSO
GSIW
Relative Strength Index (RSI) 28.17 59.67
Support Level N/A $0.11
Resistance Level $0.74 $32.25
Average True Range (ATR) 0.04 1.62
MACD -0.01 -0.59
Stochastic Oscillator 8.67 45.31

Price Performance

Historical Comparison
CTSO
GSIW

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: